MAT Options for Teens with Alcohol Use Disorder:

Antabuse 

(Disulfiram)

Campral

(Acamprosate)

Naltrexone

(Daily generic dose or long-acting monthly injection of Vivitrol)

Substance use during adolescence is a critical issue that requires immediate and comprehensive intervention. Experimentation with drugs and alcohol during the teen years may seem like a common part of growing up, but it can cause significant changes in social behaviors, impact neurological functioning, and result in serious and long-lasting challenges.

It is often hard to help an adolescent understand the danger of substance use. Adolescents may have a hard time forming cause and effect connections between the choices they make today and the long-term effects of those choices tomorrow. Peers play a large role in an adolescent’s conceptualization of the world, and teens face added stressors due to being in the midst of self-exploration and identity development, and are still growing physically and neurologically. Support and intervention for teens struggling with substance use must be meaningful, comprehensive, and timely to ensure a full and lasting recovery.

The American Academy of Pediatrics recommends that treatment providers consider medication assisted treatments (MATs) for adolescents with severe opioid use disorders. MATs are shown to reduce opioid use in the adolescent population, manage withdrawals, and reduce the risk of relapse. MAT (particularly methadone and buprenorphine) is typically indicated for patients 18 years old and older. It can be considered for patients aged 16 and 17, who have documented history of at least two prior unsuccessful withdrawal management attempts, and have parental consent.

When taken appropriately and with proper screening and assessment, MAT can be an effective tool in treating adolescents with substance use disorders. Due to unique risk factors in this age group, it is critical that clients and families work closely with counselors and prescribers to develop a comprehensive, holistic treatment approach for teens struggling with substance use.

Teen substance use is a serious issue, and caregivers must respond quickly to foster healing and help the teen achieve sustained recovery. Family therapy, development of a positive peer network, and coping skill development are especially critical when supporting an individual in this age group.

These approved medications assist with urges, cravings, withdrawal symptoms, and some act as a blocking mechanism for the euphoric effects of alcohol and opioids.

In alignment with best practice standards, Root Center uses MAT in combination with comprehensive, evidence-based psychotherapeutic programming to help individuals progress in their recovery journey. Buprenorphine, methadone, and naltrexone are the three primary FDA-approved medications that are used in the treatment of opioid use disorders (OUDs). All three have been clinically proven to be safe and effective in treating OUDs and are critical tools in helping individuals achieve a long-term recovery.

Taking medication for an OUD is the same as taking medication for any other chronic disease. You should never allow embarrassment or stigma stop you from getting help and support.